Survival causal rule ensemble method considering the main effect for estimating heterogeneous treatment effects

被引:0
|
作者
Wan, Ke [1 ]
Tanioka, Kensuke [2 ]
Shimokawa, Toshio [1 ]
机构
[1] Wakayama Med Univ, Dept Med, 811-1 Kimiidera, Wakayama 6418509, Japan
[2] Doshisha Univ, Dept Biomed Sci & Informat, Kyoto, Japan
关键词
heterogeneous treatment effect; interpretability; randomized control trial; rule ensemble; survival analysis; SUBGROUP IDENTIFICATION; CLINICAL-TRIALS;
D O I
10.1002/sim.10180
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
With an increasing focus on precision medicine in medical research, numerous studies have been conducted in recent years to clarify the relationship between treatment effects and patient characteristics. The treatment effects for patients with different characteristics are always heterogeneous, and therefore, various heterogeneous treatment effect machine learning estimation methods have been proposed owing to their flexibility and high estimation accuracy. However, most machine learning methods rely on black-box models, preventing direct interpretation of the relationship between patient characteristics and treatment effects. Moreover, most of these studies have focused on continuous or binary outcomes, although survival outcomes are also important in medical research. To address these challenges, we propose a heterogeneous treatment effect estimation method for survival data based on RuleFit, an interpretable machine learning method. Numerical simulation results confirmed that the prediction performance of the proposed method was comparable to that of existing methods. We also applied a dataset from an HIV study, the AIDS Clinical Trials Group Protocol 175 dataset, to illustrate the interpretability of the proposed method using real data. Consequently, the proposed survival causal rule ensemble method provides an interpretable model with sufficient estimation accuracy.
引用
收藏
页码:5234 / 5271
页数:38
相关论文
共 27 条
  • [21] Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times?
    Latimer, N. R.
    White, I. R.
    Abrams, K. R.
    Siebert, U.
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2019, 28 (08) : 2475 - 2493
  • [22] Heterogeneous treatment effects of coronary artery bypass grafting in ischemic cardiomyopathy: A machine learning causal forest analysis
    Zhou, Zhuoming
    Jian, Bohao
    Chen, Xuanyu
    Liu, Menghui
    Zhang, Shaozhao
    Fu, Guangguo
    Li, Gang
    Liang, Mengya
    Tian, Ting
    Wu, Zhongkai
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 168 (05)
  • [23] Estimating Treatment Effects and Predicting Recidivism for Community Supervision Using Survival Analysis with Instrumental Variables
    Rhodes, William
    JOURNAL OF QUANTITATIVE CRIMINOLOGY, 2010, 26 (03) : 391 - 413
  • [24] Estimating Treatment Effects and Predicting Recidivism for Community Supervision Using Survival Analysis with Instrumental Variables
    William Rhodes
    Journal of Quantitative Criminology, 2010, 26 : 391 - 413
  • [25] Estimating the causal effect of a time-varying treatment on time-to-event using structural nested failure time models
    Lok, J
    Gill, R
    van der Vaart, A
    Robins, J
    STATISTICA NEERLANDICA, 2004, 58 (03) : 271 - 295
  • [26] A sequential stratification method for estimating the effect of a time-dependent experimental treatment in observational studies
    Schaubel, Douglas E.
    Wolfe, Robert A.
    Port, Friedrich K.
    BIOMETRICS, 2006, 62 (03) : 910 - 917
  • [27] Baseline and treatment effect heterogeneity for survival times between centers using a random effects accelerated failure time model with flexible error distribution
    Komarek, Arnost
    Lesaffre, Emmanuel
    Legrand, Catherine
    STATISTICS IN MEDICINE, 2007, 26 (30) : 5457 - 5472